Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Email today from Matt P.

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Dec 12, 2024 12:42pm

159 Views

Post# 36359218

RE:RE:RE:RE:RE:Email today from Matt P.

We blame the FDA who is funded by big pharmaceutical companies but here in Canada we have an agency called Health Canada who at anytime could grant approval for this drug and treatment, saving billions of dollars for our healthcare system and taking away people's pain and suffering and possibly saving their lives.

PS
we could be in the medical tourism business reaping billions in revenue while we wait for FDA approval
You would think this would be an easy decision for the government and a win win for everyone

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste